insights_auto
Why is IKT up 3,14%?
Dive Deeperchevron_right
IKT:NASDAQ
Inhibikase Therapeutics Inc
1,97 USD
arrow_upward
+3,14%(+0,060) 1D
1,97 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 9-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IKT...
Open
1,90 USD
High
1,98 USD
Low
1,87 USD
Mkt. cap
274,89 млн
Avg. vol.
518,16 миң
Volume
435,03 миң
52-wk high
2,61 USD
52-wk low
1,33 USD
EPS
-0,44 USD
Beta
0,89
Shares outstanding
139,54 млн
No. of employees
35
Open
1,90 USD
High
1,98 USD
Low
1,87 USD
Mkt. cap
274,89 млн
Avg. vol.
518,16 миң
Volume
435,03 миң
52-wk high
2,61 USD
52-wk low
1,33 USD
EPS
-0,44 USD
Beta
0,89
Shares outstanding
139,54 млн
No. of employees
35
News stories
From web sources and news partners
TradingView
·
24 мүнөт мурун
TRex Bio, Clinical-Stage Immunology Biopharma, Files for Nasdaq Global Select Market IPO
Quiver Quantitative
·
23 мүнөт мурун
Axe Compute Inc. to Ring Nasdaq Opening Bell Amid AI Infrastructure Growth and $3.45 Billion in Signed Contracts
GuruFocus
·
1 саат мурун
Nasdaq CEO Flags Tens of Billions in New Wall Street Opportunity
Yahoo Finance
·
5 саат мурун
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersУилмингтон, Делавэр, Америка Кошмо Штаттары
Sector-
Websiteinhibikase.com